Green tea extract reported to show promise against leukemia

Scientists are reporting positive results in early leukemia clinical trials using the chemical epigallocatechin gallate, a subtance in green tea. The findings appeared in the Journal of Clinical Oncology. Green tea is made with the leaves of Camellia Sinesis, a shrub native to Asia. After the research showed dramatic effectiveness in killing leukemia cells, the findings were applied to studies on animal tissues and then on human cells in the lab. The research has moved to the second phase of clinical testing in a follow-up trial, already fully enrolled, involving roughly the same number of patients. All will receive the highest dose administered from the previous trial.

http://www.world-science.net/othernews/090526-gallate.htm

Share |